Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfarma Laboratorio S.L.filedCriticalGenfarma Laboratorio S.L.
Publication of RS51179BpublicationCriticalpatent/RS51179B/sr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Vodeni rastvor paracetamola za upotrebu u perfuziji, sa pH između 4-5 i 6.0, naznačen time što rastvor sadrži stabilizujuću substancu paracetamola u rastvoru koji se sastoji od glukoze u koncentraciji između 0.4% m/v i 3.3% m/v. Prijava sadrži još 9 zavisnih patentnih zahteva.
Metodo para producir cloramina estable que comprende combinar fuente de cloro concentrado con fuente de amina concentrada y agitar para producir cloramina estable con ph>5.
Solucion farmaceutica que tiene un ph de 10 o superior, que contiene telmisartan en concentracion de 1 a 10mg/ml y uno o mas azucar-alcoholes en concentracion de 40-70% (de preferencia 60-70%); metodo de preparacion; uso para el tratamiento de la hipertension o lesiones renales; y recipiente de vidrio o plastico que la contiene.